BiotechTube
Home/Synlogic/Brendan St. Amant
BS

Brendan St. Amant

Vice President, Head of Legal

Synlogic

Therapeutic Areas

Metabolic DisordersRare Diseases

Synlogic Pipeline

DrugIndicationPhase
SYNB1934Phenylketonuria (PKU)Phase 3
SYNB1353Homocystinuria (HCU)Phase 1/2a